27851-29-2 Usage
Description
1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE is a white powder chemical compound that serves as an intermediate in the synthesis of various complex organic molecules. It is a derivative of beta-D-glucopyranose, a monosaccharide, with four benzyl groups attached to its hydroxyl groups, which significantly alters its chemical properties and reactivity.
Uses
Used in Pharmaceutical Industry:
1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE is used as an intermediate in the synthesis of complex organic molecules, particularly in the pharmaceutical industry. Its unique structure allows for the creation of novel drug candidates with potential therapeutic applications.
Used in Organic Synthesis:
1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE is used as a key intermediate in organic synthesis for the preparation of various biologically active compounds. Its benzyl-protected hydroxyl groups provide a versatile platform for further functionalization and modification, enabling the development of new chemical entities with potential applications in medicine, agrochemicals, and other fields.
Used in the Synthesis of Isomaltose-13C (I821252):
1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE is used as an intermediate in the synthesis of Isomaltose-13C (I821252), a labeled isomaltose compound. 1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE is one of the main products of the transformation of maltose into prebiotic isomaltooligosaccharides by novel α-glucosidase from Xanthophillomyces dendrorhous. The synthesis of such labeled compounds is essential for research and development in various scientific fields, including biochemistry, molecular biology, and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 27851-29-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,8,5 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 27851-29:
(7*2)+(6*7)+(5*8)+(4*5)+(3*1)+(2*2)+(1*9)=132
132 % 10 = 2
So 27851-29-2 is a valid CAS Registry Number.
InChI:InChI=1/C34H36O6/c35-21-30-31(36-22-26-13-5-1-6-14-26)32(37-23-27-15-7-2-8-16-27)33(38-24-28-17-9-3-10-18-28)34(40-30)39-25-29-19-11-4-12-20-29/h1-20,30-35H,21-25H2/t30?,31-,32+,33+,34-/m1/s1
27851-29-2Relevant articles and documents
Synthesis and conformational analysis of D-gluco-pyranosyl-(6,6′)-D-gluco-pyranuronate, a model compound for the inter-glycan 6,6′-ester linkage
Hackbusch, Sven,Watson, Amelia,Franz, Andreas H.
, p. 1 - 12 (2018)
The synthesis of a 6,6′-ester linked disaccharide analog model compound was achieved in five steps from D-glucose and featured a key oxidative esterification transformation. The synthesized D-gluco-pyranosyl-(6,6′)-D-gluco-pyranuronate was characterized in D2O using NMR spectroscopy. Using the experimental data together with molecular dynamics simulations (TIP3P, water), a model of the compound's conformational behavior was established. The effect of the 6,6′-ester linkage on the solution phase structure was compared to that of the previously reported 6,6′-ether linkage in a disaccharide analog. Based on the established models, the ester linkage was found to have a profound effect on the overall shape of the molecule.
New class of alkynyl glycoside analogues as tyrosinase inhibitors
Saehlim, Natthiya,Athipornchai, Anan,Sirion, Uthaiwan,Saeeng, Rungnapha
supporting information, (2020/06/01)
A new series of alkynyl glycoside analogues were designed and synthesized from cheap and a commercially available sugar by introduction of various alkynyl and alkyl groups at C-1 and C-6 positions of the sugar ring. The inhibitory abilities of alkynyl gly
ELECTROCHEMICAL METHODS AND COMPOUNDS FOR THE DETECTION OF ENZYMES
-
, (2016/04/26)
Disclosed are compositions and methods for the electrochemical detection of enzymes, such as enzymes that are indicative of disease, disorders, or pathogens, such as viruses, bacteria, and fungi, or other disorders. These methods can be used in point-of- care diagnostic assays for the detection of disease, disorder, or pathogen (e.g., to identify the strain of pathogen infecting a patient in a healthcare setting). The electrochemical methods described herein can also be used to assess the susceptibility of a pathogen to an antipathogen drug. Also provided are probes suitable for use in conjunction with the methods described herein.